Literature DB >> 31051080

Comprehensive Supportive Care for Patients with Fibrosing Interstitial Lung Disease.

Marlies S Wijsenbeek1, Anne E Holland2,3,4, Jeffrey J Swigris5, Elisabetta A Renzoni6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31051080     DOI： 10.1164/rccm.201903-0614PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  11 in total

1.  The telemedicine experience: using principles of clinical excellence to identify disparities and optimize care.

Authors:  Sheena Khan; Edward J Llinas; Sonye K Danoff; Rafael H Llinas; Elisabeth B Marsh
Journal:  Medicine (Baltimore)       Date:  2022-03-11       Impact factor: 1.817

2.  Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.

Authors:  Marlies Wijsenbeek; Maria Molina-Molina; Olivier Chassany; John Fox; Liam Galvin; Klaus Geissler; Katherine M Hammitt; Michael Kreuter; Teng Moua; Emily C O'Brien; Ashley F Slagle; Anna Krasnow; Matthew Reaney; Michael Baldwin; Natalia Male; Klaus B Rohr; Jeff Swigris; Katerina Antoniou
Journal:  ERJ Open Res       Date:  2022-05-03

Review 3.  The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.

Authors:  Anna-Maria Hoffmann-Vold; Yannick Allanore; Elisabeth Bendstrup; Cosimo Bruni; Oliver Distler; Toby M Maher; Marlies Wijsenbeek; Michael Kreuter
Journal:  Respir Res       Date:  2020-07-23

4.  Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need.

Authors:  Amanda T Goodwin; Gauri Saini
Journal:  Breathe (Sheff)       Date:  2020-09

5.  Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries.

Authors:  Abigél Margit Kolonics-Farkas; Martina Šterclová; Nesrin Mogulkoc; Katarzyna Lewandowska; Veronika Müller; Marta Hájková; Mordechai Kramer; Dragana Jovanovic; Jasna Tekavec-Trkanjec; Michael Studnicka; Natalia Stoeva; Simona Littnerová; Martina Vašáková
Journal:  Front Med (Lausanne)       Date:  2021-12-23

6.  Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.

Authors:  Takafumi Koyauchi; Yuzo Suzuki; Kazuki Sato; Hironao Hozumi; Masato Karayama; Kazuki Furuhashi; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Koshi Yokomura; Shiro Imokawa; Hidenori Nakamura; Tatsuya Morita; Takafumi Suda
Journal:  Respir Res       Date:  2022-04-04

Review 7.  Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis.

Authors:  Surabhi Agarwal Khanna; John W Nance; Sally A Suliman
Journal:  Curr Rheumatol Rep       Date:  2022-05-01       Impact factor: 4.686

8.  Bone mesenchymal stem cell-derived exosomes prevent hyperoxia-induced apoptosis of primary type II alveolar epithelial cells in vitro.

Authors:  Wei Yang; Chao Huang; Wenjian Wang; Baozhu Zhang; Yunbin Chen; Xinlin Xie
Journal:  PeerJ       Date:  2022-09-02       Impact factor: 3.061

9.  End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report.

Authors:  Ken Goda; Tsuneaki Kenzaka; Kyosuke Kuriyama; Masahiko Hoshijima; Hozuka Akita
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

10.  Management of patients with fibrosing interstitial lung diseases.

Authors:  Lee E Morrow; Daniel Hilleman; Mark A Malesker
Journal:  Am J Health Syst Pharm       Date:  2022-01-24       Impact factor: 2.637
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.